Table 1. Participant Characteristics at Time of Fracture by Multimorbidity Clusters.
Characteristics | Multimorbidity disease clustera | ||||||||
---|---|---|---|---|---|---|---|---|---|
Men (n = 95 372) | Women (n =212 498) | ||||||||
Low multimorbidity | Cardiovascular | Diabetic | Malignant | Hepatic and/or inflammatoryb | Low multimorbidity | Cardiovascular | Diabetic | Malignant | |
All | 57 711 (60.5) | 22 589 (23.7) | 5315 (5.6) | 4907 (5.1) | 4850 (5.1) | 141 222 (66.5) | 49 932 (23.5) | 10 697 (5.0) | 10 647 (5.0) |
Age at fracture, mean (SD), y | 70.2 (11.3) | 78.2 (9.8) | 72.0 (9.3) | 72.8 (9.4) | 70.6 (10.3) | 73.1 (11.3) | 80.2 (9.7) | 75.5 (9.6) | 73.2 (9.7) |
Comorbidities, median (IQR) No. | 1.0 (0-1.0) | 4.0 (3.0-5.0) | 5.0 (4.0-7.0) | 3.0 (2.0-4.0) | 4.0 (3.0-5.0) | 0 (0-1.0) | 3.0 (2.0-4.0) | 4.0 (3.0-6.0) | 3.0 (2.0-3.0) |
No. of comorbidities | |||||||||
0 | 26 632 (46.1) | 0 | 0 | 0 | 0 | 73 740 (52.2) | 0 | 0 | 0 |
1 | 20 156 (34.9) | 0 | 0 | 0 | 272 (5.6) | 53 124 (37.6) | 390 (0.8) | 0 | 0 |
2 | 9874 (17.1) | 3612 (16.0) | 302 (5.7) | 1875 (38.2) | 802 (16.5) | 13 812 (9.8) | 12 911 (25.9) | 1650 (15.4) | 4234 (39.8) |
3-4 | 1049 (1.8) | 12 569 (55.6) | 1602 (30.1) | 2412 (49.1) | 2206 (45.5) | 546 (0.4) | 26 206 (52.5) | 3946 (36.9) | 5418 (50.9) |
≥5 | 0 | 6408 (28.4) | 3411 (64.2) | 620 (12.6) | 1570 (32.4) | 0 | 10 425 (20.9) | 5101 (47.7) | 995 (9.3) |
Specific comorbiditiesc | |||||||||
Myocardial infarction | 2139 (3.7) | 6675 (29.5) | 1434 (27.0) | 335 (6.8) | 568 (11.7) | 1990 (1.4) | 9322 (18.7) | 2111 (19.7) | 258 (2.4) |
Congestive heart failure | 714 (1.2) | 9799 (43.4) | 1872 (35.2) | 498 (10.1) | 887 (18.3) | 2044 (1.4) | 16 261 (32.6) | 2968 (27.7) | 423 (4.0) |
Peripheral vascular disease | 2071 (3.6) | 4833 (21.4) | 1947 (36.6) | 445 (9.1) | 604 (12.5) | 3463 (2.5) | 7247 (14.5) | 2262 (21.1) | 544 (5.1) |
Cerebrovascular disease | 7266 (12.6) | 9862 (43.7) | 2070 (38.9) | 584 (11.9) | 1252 (25.8) | 10 250 (7.3) | 19 633 (39.3) | 3868 (36.1) | 2665 (25.0) |
Cardiac valvular disease | 115 (0.2) | 2097 (9.3) | 309 (5.8) | 110 (2.2) | 181 (3.7) | 296 (0.2) | 4456 (8.9) | 520 (4.9) | 155 (1.5) |
Cardiac arrhythmias | 1302 (2.3) | 8854 (39.2) | 1184 (22.3) | 357 (7.3) | 748 (15.4) | 2388 (1.7) | 14 793 (29.6) | 1766 (16.5) | 460 (4.3) |
Diabetes without chronic complications | 2632 (4.6) | 2907 (12.9) | 5146 (96.8) | 621 (12.7) | 779 (16.1) | 3737 (2.6) | 3343 (6.7) | 10 293 (96.2) | 1171 (11.0) |
Diabetes with chronic complications | 210 (0.4) | 66 (0.3) | 4744 (89.3) | 12 (0.2) | 135 (2.8) | 227 (0.2) | 0 | 5862 (54.8) | 6 (0.1) |
Any malignant neoplasm except skin | 8210 (14.2) | 4997 (22.1) | 1156 (21.7) | 4907 (100) | 1109 (22.9) | 16 896 (12.0) | 7857 (15.7) | 3008 (28.1) | 10 647 (100) |
Metastatic solid tumor | 188 (0.3) | 175 (0.8) | 186 (3.5) | 3324 (67.7) | 167 (3.4) | 386 (0.3) | 309 (0.6) | 222 (2.1) | 5936 (55.7) |
Rheumatic or rheumatoid arthritis or collagen vascular diseases | 445 (0.8) | 186 (0.8) | 265 (5.0) | 39 (0.8) | 2390 (49.3) | 5983 (4.2) | 4931 (9.9) | 1039 (9.7) | 794 (7.5) |
Mild liver disease | 484 (0.8) | 93 (0.4) | 278 (5.2) | 88 (1.8) | 1976 (40.7) | 982 (0.7) | 1706 (3.4) | 552 (5.2) | 356 (3.3) |
Moderate or severe liver disease | 32 (0.1) | 8 (0.03) | 100 (1.9) | 16 (0.3) | 1052 (21.7) | 53 (0.03) | 673 (1.3) | 203 (1.9) | 136 (1.3) |
Hypertension | 2250 (3.9) | 8779 (38.9) | 2526 (47.5) | 1078 (22.0) | 963 (19.9) | 6167 (4.4) | 21 136 (42.3) | 4734 (44.3) | 1679 (15.8) |
Chronic pulmonary disease | 4789 (8.3) | 7394 (32.7) | 1233 (23.2) | 864 (17.6) | 1191 (24.5) | 10 331 (7.3) | 14 276 (28.6) | 2328 (21.8) | 2168 (20.4) |
Pulmonary circulation disorders | 138 (0.2) | 671 (3.0) | 109 (2.1) | 106 (2.2) | 69 (1.4) | 158 (0.1) | 1542 (3.1) | 184 (1.7) | 169 (1.6) |
Dementia | 3487 (6.0) | 4168 (18.5) | 575 (10.8) | 102 (2.1) | 439 (9.1) | 8326 (5.9) | 10 455 (20.9) | 1146 (10.7) | 388 (3.6) |
Psychoses | 164 (0.3) | 163 (0.7) | 26 (0.5) | 13 (0.3) | 35 (0.7) | 203 (0.1) | 439 (0.9) | 56 (0.5) | 29 (0.3) |
Depression | 283 (0.5) | 1487 (6.6) | 219 (4.1) | 87 (1.8) | 278 (5.7) | 397 (0.3) | 5067 (10.1) | 420 (3.9) | 312 (2.9) |
Paralysis or hemiparaplegia | 344 (0.6) | 340 (1.5) | 94 (1.8) | 97 (2.0) | 66 (1.4) | 402 (0.3) | 423 (0.8) | 86 (0.8) | 141 (1.3) |
Neurological disorders | 1881 (3.3) | 2108 (9.3) | 265 (5.0) | 105 (2.1) | 344 (7.1) | 2372 (1.7) | 3227 (6.5) | 357 (3.3) | 302 (2.8) |
Peptic ulcer disease | 2197 (3.8) | 3575 (15.8) | 733 (13.8) | 475 (9.7) | 1064 (21.9) | 4307 (3.0) | 7839 (15.7) | 1284 (12.0) | 816 (7.7) |
Chronic renal disease | 357 (0.6) | 3277 (14.5) | 1362 (25.6) | 377 (7.7) | 386 (8.0) | 428 (0.3) | 3634 (7.3) | 1749 (16.3) | 451 (4.2) |
Hypothyroidism | 82 (0.1) | 325 (1.4) | 83 (1.6) | 40 (0.8) | 46 (0.9) | 794 (0.6) | 2645 (5.3) | 625 (5.8) | 230 (2.2) |
Coagulopathy | 46 (0.1) | 257 (1.1) | 51 (1.0) | 62 (1.3) | 112 (2.3) | 108 (0.1) | 407 (0.8) | 96 (0.9) | 70 (0.7) |
Obesity | 135 (0.2) | 425 (1.9) | 594 (11.2) | 62 (1.3) | 103 (2.1) | 447 (0.3) | 1040 (2.1) | 1223 (11.4) | 319 (3.0) |
Unintended weight loss | 60 (0.1) | 321 (1.4) | 70 (1.3) | 75 (1.5) | 96 (2.0) | 89 (0.1) | 923 (1.8) | 90 (0.8) | 89 (0.8) |
Fluid or electrolyte disorders | 634 (1.1) | 3055 (13.5) | 507 (9.5) | 208 (4.2) | 443 (9.1) | 937 (0.7) | 8773 (17.6) | 890 (8.3) | 556 (5.2) |
Anemia | 118 (0.2) | 974 (4.3) | 175 (3.3) | 106 (2.2) | 213 (4.4) | 285 (0.2) | 2562 (5.1) | 301 (2.8) | 200 (1.9) |
Alcohol abuse | 215 (0.4) | 72 (0.3) | 117 (2.2) | 24 (0.5) | 1409 (29.1) | 72 (0.1) | 794 (1.6) | 147 (1.4) | 86 (0.8) |
Drug abuse | 45 (0.1) | 71 (0.3) | 18 (0.3) | 4 (0.1) | 58 (1.2) | 29 (0.02) | 273 (0.5) | 18 (0.2) | 10 (0.1) |
HIV/AIDS | 27 (0.05) | 17 (0.1) | 3 (0.1) | 5 (0.1) | 8 (0.2) | 7 (0.01) | 2 (0.004) | 2 (0.02) | 5 (0.05) |
Data are presented as No. (%), unless indicated otherwise.
Data were collected for men only.
Includes not only chronic diseases that require hospitalization, but also those documented as either secondary diagnoses or at outpatient or emergency visits.